Pharma CRM Goes on the iPad and iPhone

Media-SoftMedia-Soft, CRM solutions provider for pharmaceutical companies, announced the launch of the native and offline iPhone adn iPad Pharma CRM application with advanced and unique features that increase the Sales Force effectiveness in pharma organizations.

"Fast, simple, functional and revolutionary are the main goals of our Sales Force Effectiveness solutions for the iPhone, iPad and iPod Touch platforms. Now every sales rep can handle customers offline on the iPad, iPhone or iPod Touch via Sales Vision iTouch application, it's so simple," commented Mr. Damir Safaric, Media-Soft CEO. "It is called Sales Vision iTouch, the best way for Pharma CRM that can revolutionize the pharma processes and increase the sales rep efficiency."

The Pharma CRM application has a simple and comfortable natural user interface that has retained all the functionality of the original Sales Vision® and in special the access to the database online and offline, all actions can be moved to the PC version through the user friendly and intuitive touch screen navigation. Also Sales Vision iTouch enables a parallel use of platforms, so a sales rep can use the iPhone or iPad on the sales field and when he arrives home he can add new information's via his PC version, Sales Vision 9 WIN.

"There are many reasons why Sales Vision CRM goes to the iPhone. Sales Vision® and iPhone are similar because they both have remained true to its roots. Both operate in niches and seek to satisfy their customers. Sales Vision® looks better than ever on iPhone. Also if you look ten years ago, the main add value and motivation factor for a sales rep was to gain a laptop. Times have changed and today the add value is to have the best Smartphone," concluded Mr. Safaric.

For further information, please visit:
http://www.media-soft.info

About Media-Soft
The story of Media Soft begins in 1996 when a visionary man started up a company that must be the best in the pharmaceutical field. Today that mission is done, Media-Soft operates in more then 30 countries worldwide, on 3 continents and has over 6.000 licensed users of its software Sales Vision®. Media Soft is established on many locations. The HQ is in Cakovec and London. We also have partners and support teams worldwide in following countries: Mexico City, Bratislava, Warszawa and Moscow. Some of the customer are Pfizer, Krka, Sandoz, Solvay, Abbott, Alkaloid, GSK, Nycomed, Roche, Bayer Schering Pharma and many others.

Most Popular Now

Amgen and Allergan's MVASI™ (bevacizumab-awwb) and…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a bio...

Compound found in red wine opens door for new trea…

Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is ...

HIV vaccine nears clinical trial following new fin…

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar p...

Mylan and Upjohn, a division of Pfizer, to combine…

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's o...

Leading oncologists and nutritionists pinpoint are…

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship betwe...

Closing the door: breaking new ground related to a…

In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid g...

FDA approves first generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associat...

Roche and Spark Therapeutics, Inc. announce extens…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced...

FDA approves first treatment for severe hypoglycem…

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that c...

Rye is healthy, thanks to an interplay of microbes

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribut...

GSK completes transaction with Pfizer to form new …

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advi...

Eating more plant-based foods may be linked to bet…

Eating mostly plant-based foods and fewer animal-based foods may be linked to better heart health and a lower risk of dying from a heart attack, stroke or other cardiovas...